Prostate Cancer Vaccines

Clinical trial NCT07068555 · RECRUITING

Trial details

NCT number: NCT07068555
Sponsor: Shenzhen Geno-Immune Medical Institute
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Indications

Start date: 2025-06-15
Primary completion: 2028-06-15
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.